CatalystWireBeta

UK small-cap RNS · 11 Nov 2025

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus the ones that are part of a situation. Not investment advice.

Sort: Newest · Largest companies
  1. 11:00
    Investor webinar to discuss Q3 2025 Results Results
    Thor is pleased to announce that Segun Lawson, President and CEO, will provide a live investor session via the Investor Meet Company platform on Thursday 20 November 2025 at 2:00pm GMT.
    +0.8% on the day
  2. 07:00
    ACCRUFeR Pediatric PK Results to be Presented Results
    ACCRUFeR® Pediatric Pharmacokinetic (PK) Results Will be Presented at the American Society of Hematology (ASH) Conference
    +3.0% on the day
  3. 07:00
    Final Results Results
    Final Results for the financial year ended 30 June 2025
    first since Oct 2023 −7.1% on the day
  4. 07:00
    Third Quarter 2025 Results Results
    HOUSTON - November 11, 2025 - VAALCO Energy, Inc.
    first in 6 months +3.4% on the day
  5. 07:00
    Results for the 15-month period ended 30 June 2025 Results
    Restated revenue of £39.5m and adjusted EBITDA of £2.2m top the earlier £38m and ~£2.0m markers, and growth is strong. The £11.3m exceptional charge is mostly non-cash impairment.
    £39.5m · 234% of mcapahead of expectationsoutlook positivefirst in 11 months −13.8% on the day
    Moved: Return to revenue and profit growth in FY25: pending → delivered – Revenue and adjusted EBITDA both grew strongly on an annualised basis, and adjusted PBT swung from a loss to a profit. · Deliver FY25 results in line with market expectations: pending → delivered – Company says results would have been slightly ahead of market expectations before the revised revenue recognition policy. · Revenue above £38m for the 15 months to June 2025: pending → delivered – Revenue of £39.5m under the revised policy is above the £38m marker.
  6. 07:00
    Half-year Results Results
    H1 revenue fell 7.9% OCC and adjusted operating profit 22.9% after tariff and US funding disruption in Q1; full-year is only guided to the October trading update, so the H2 recovery must carry the year.
    Segment turn £57.0m · 4% of mcapin lineoutlook positive3 business updates in 3 months – usually less than 1 +15.0% on the day
    Moved: new: NanoScience business sale – Agreed; awaiting regulatory approvals · new: Imaging & Analysis recovery – H1 actions taken; H2 recovery expected
  7. 07:00
    Final Results Results
    The rule read this as an upgrade, but the Board only expects FY2026 adjusted operating profit in line with current expectations (£24.5m mean), with a second-half bias and warning of possible H1 disruption.
    ahead of expectationsoutlook mixed +0.8% on the day
    Moved: CEO transition: Successor named; handover under way → Handover under way; Matthews-DeMers is CEO designate
  8. 07:00
    FY26 Interim Results Results
    The interim results do not raise guidance. The Board only says it is confident of the already-upgraded Investec expectation of $8.5m underlying operating profit (6 October 2025), which H1's $5.5m is on course to support.
    ahead of expectationsoutlook positivefirst since Oct 2023 +8.4% on the day
    Moved: new: Transformation Plan – Operational and financial phases delivering; sales lagging · new: Sanmina liability settlement – Accelerated payment agreed October 2025
  9. 07:00
    MCB metallurgical testing results Results
    Metallurgical Testing shows high Copper Recoveries at the MCB Project
    −8.7% on the day

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note